Article metrics

Download PDFPDF
CP-242 Bevacizumab in glioblastoma or anaplasic astrocytoma: effectiveness, safety and cost effectiveness analysis

 

Online download statistics by month:

Online download statistics by month: March 2017 to January 2024

AbstractFullPdf
Mar 20172907
Apr 2017800
May 20171500
Jun 20171001
Jul 20171200
Aug 20172401
Sep 20171202
Oct 20175201
Nov 20172201
Dec 20172200
Jan 20186200
Feb 20182400
Mar 20183400
Apr 20185601
May 20181600
Jun 20183000
Jul 20181200
Aug 20181200
Sep 2018200
Oct 20182600
Nov 20184600
Dec 20185000
Jan 20193600
Feb 20192100
Mar 20191000
Apr 2019801
May 2019200
Jun 2019400
Jul 2019400
Aug 2019400
Sep 20191000
Oct 20191000
Dec 2019600
Jan 2020200
Feb 2020400
May 2020901
Jun 2020600
Jul 2020800
Aug 2020201
Sep 20201000
Oct 2020400
Nov 2020200
Dec 2020400
Jan 2021600
Feb 2021100
Apr 2021400
May 2021400
Jun 2021200
Jul 2021002
Nov 20211600
Dec 2021600
Jan 2022200
Feb 2022300
Mar 2022900
Apr 2022600
May 20221401
Jun 20222300
Jul 2022600
Aug 2022800
Sep 2022400
Oct 2022400
Nov 20221400
Dec 2022900
Jan 2023200
Feb 2023200
Mar 20234400
Apr 2023500
May 2023400
Jul 20231300
Aug 20231000
Sep 2023800
Oct 20231602
Nov 2023400
Dec 20231000
Jan 2024200
Total1003022